The many faces of secondary syphilis: A re-emergence of an old disease

Clinical and Experimental Dermatology

Volumn 31, Issue 5, 2006, Pages 741-745

  Angus, J ^a   Langan, S M ^a   Stanway, A ^a   Leach, I H ^a   Littlewood, S M ^a   English, J S ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BENZATHINE; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

ARTICLE; CLINICAL FEATURE; GENITAL ULCER; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY SYPHILIS; SEXUALLY TRANSMITTED DISEASE; SYPHILIS SEROLOGY; TREPONEMA PALLIDUM;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PENICILLINS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; SYPHILIS; SYPHILIS SERODIAGNOSIS;

EID: 33746159856     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02163.x     Document Type: Article

References (15)

1. Simms I, Fenton KA, Ashton M et al. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex Transm Dis 2005; 32: 220-6.
2. Kingston MA, Higgins SP. Audit of the management of early syphilis at North Manchester General Hospital. Int J STD AIDS 2004; 80: 352-4.
3. Mindel A, Tovey SJ, Timmins DJ et al. Primary and secondary syphilis, 20 years experience. Genitourin Med 1989; 65: 1-3.
4. Fisher DA, Chang LW, Tuffanelli DL. Lues maligna: presentation of a case and review of the literature. Arch Dermatol 1969; 99: 70-3.
5. Don CD. Malignant syphilis (lues maligna) and concurrent HIV infection. Int J Dermatol 1997; 34: 403-7.
6. Watson KMT, White JML, Salisbury JR et al. Lues maligna. Clin Exp Dermatol 2004; 29: 625-7.
7. Pournaras CC, Masouye I, Piletta P et al. Extensive annular verrucous late secondary syphilis. Br J Dermatol 2005; 6: 1343-5.
8. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted disease to sexual transmission of HIV infection. Sex Trans Infect 1999; 75: 3-17.
9. Katz MH, Schwarcz SK, Kellogg TA et al. Impact of highly active antiretroviral treatment on HIV sero-incidence among men who have sex with men: San Francisco. Am J Public Health 2002; 92: 388-94.
10. Lynn WA, Lightman S. Syphilis and HIV. a dangerous combination. Lancet Infect Dis 2004; 4: 456-66.
11. Rogstad KE, Simms I, Fenton K et al. Screening, diagnosis and management of early syphilis in genitourinary medicine clinics in UK. Int J STD AIDS 2005; 16: 348-52.
12. Blum L, Bachmeyer C, Caumes E. Seronegative secondary syphilis in an HIV-infected patient. Clin Exp Derm 2004; 30: 158-9.
13. Romanowski B, Sutherland R, Fick GH et al. Serological response to treatment of infectious syphilis. Ann Inter Med 1991; 114: 1005-9.
14. Abell E, Marks R, Jones EW. Secondary syphilis: a clinico-pathological review. Br J Dermatol 1975; 93: 53-61.
15. Goh B. UK National Guidelines on the Management of Early Syphilis. MSSVD Syphilis Guidelines Revision Group. 2002. Available at: http://www.bashh.org/ guidelines/2002/early$final0502.pdf.